Remove Clinical Development Remove Protein Expression Remove Protein Production
article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

This presentation covered three primary drivers for a protein expression model: speed, cost and sustainability. “It Field also covered the capabilities and strategies that enable acceleration of Fc-fusion, Fab fragment and bispecific antibodies through pre-clinical development.

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Nageatte Ibrahim, MD, Vice President, Oncology & Global Clinical Development, MSD, on: ‘The new age of immunotherapy: From checkpoint inhibitors to vaccines’. These topics include: High-throughput (HTP) protein production and AI and automation in bioprocess development.